STOCKWATCH
·
Biotechnology: Laboratory Analytical Instruments
Quarterly ResultMay 14, 2026, 04:22 PM

Precipio Q1 Net Loss $(1.44)M; Sales $6.71M; Going Concern Doubt

AI Summary

Precipio, Inc. reported a net loss of $(1.44) million for the first quarter of 2026, an increase from $(0.88) million in the prior year. Net sales grew to $6.71 million, up 36.15% year-over-year. Despite generating positive cash flow from operations, the company expressed substantial doubt about its ability to continue as a going concern for the next twelve months due to accumulated deficits and ongoing operating losses.

Key Highlights

  • Net loss increased to $(1.44) million in Q1 2026 from $(0.88) million in Q1 2025.
  • Net sales rose 36.15% to $6.71 million in Q1 2026 from $4.93 million in Q1 2025.
  • Basic and diluted loss per common share was $(0.81) in Q1 2026, compared to $(0.59) in Q1 2025.
  • Gross profit increased to $2.73 million in Q1 2026 from $2.14 million in Q1 2025.
  • Net cash provided by operating activities was $0.06 million in Q1 2026, up from $(0.04) million used in Q1 2025.
  • Company reported substantial doubt about its ability to continue as a going concern.
  • Cash balance at March 31, 2026, was $2.60 million, a slight decrease from $2.65 million at Dec 31, 2025.
  • Final repayment of $0.1 million made to Change Healthcare Temporary Funding Assistance Program.
PRPO
Biotechnology: Laboratory Analytical Instruments
Precipio, Inc.

Price Impact